AstraZeneca
oncology positioned to address the full spectrum of breast cancer | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
November 2022
Slide
34 of 44
Similar slides by AstraZeneca
See diffirences between slides (animation)
Investor Day
June 2022
positioned to address the full spectrum of breast cancer | AstraZeneca
Related slides by other companies
Dare Bioscience
Investor Presentation
February 2023
dare | Dare Bioscience
Alkermes
Investor Day
March 2021
potential clinical utility limited by severe toxicities clinical evaluation limited due to severe toxicities associated with systemic exposure to and its narrow therapeutic index systemic administration associated with the potential for rapid development of lethal inflammatory syndrome ongoing efforts in seeking to develop strategies for tumor localized delivery gene therapy viral delivery primarily based on it administration alkermes design intentions for engineered harness the therapeutic potential of address delivery challenges associated with it approaches avoid toxicity associated with systemic exposure to cancer front cancer res august cancer res index | Alkermes
Immatics
Investor Presentation
November 2023
potential for large patient populations across multiple solid cancers so | Immatics
BioNTech
Results
August 2021
potential to tackle multiple diseases with different therapeutic modalities | BioNTech
Other recent decks by AstraZeneca
See all presentations (27 decks)
Results
February 2024
Investor Conference
January 2024
Results
November 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io